CSIMarket
 
Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 
 
Price: $127.6100 $2.63 2.104%
Day's High: $125.345 Week Perf: 4.74 %
Day's Low: $ 124.45 30 Day Perf: 4.09 %
Volume (M): 21 52 Wk High: $ 149.25
Volume (M$): $ 2,679 52 Wk Avg: $124.56
Open: $124.94 52 Wk Low: $102.05



 Market Capitalization (Millions $) 26,798
 Shares Outstanding (Millions) 210
 Employees 19,500
 Revenues (TTM) (Millions $) 7,279
 Net Income (TTM) (Millions $) 475
 Cash Flow (TTM) (Millions $) -253
 Capital Exp. (TTM) (Millions $) 378

Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings Inc is a global medical device company that specializes in the design and manufacturing of orthopedic and musculoskeletal healthcare products. The company offers a wide range of products, including joint replacement devices, surgical tools, and biologics, to help healthcare professionals in providing effective and innovative solutions to their patients. With a focus on constant research and development, Zimmer Biomet aims to improve the quality of life for people suffering from musculoskeletal disorders and injuries. They operate in over 100 countries and have a strong presence in the orthopedic market, making them one of the leading companies in the industry.


   Company Address: 345 East Main Street Warsaw 46580 IN
   Company Phone Number: 373-3333   Stock Exchange / Ticker: NYSE ZBH
   ZBH is expected to report next financial results on February 23, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc's Fiscal Third Quarter Sees Mixed Results with 16.3% Drop in Earnings per Share

Zimmer Biomet Holdings Inc Faces Mixed Performance in Fiscal Third Quarter
In the fiscal third quarter of 2023, medical equipment and supplies company Zimmer Biomet Holdings Inc (ZBH) reported different earnings results. While the company experienced a 5.019% increase in revenue to $1.75 billion compared to the previous year, its income fell by -16.3% to $0.77 per share from $0.92 per share in the prior year reporting period.
The revenue decrease of -6.205% from the previous quarter, coupled with a -23% decline in income from $1.00 per share, paints a varied picture for investors. However, Zimmer Biomet Holdings Inc remains determined to prioritize considered spending and investments, development, and personnel to create long-term value for stakeholders.

Zimmer Biomet Holdings Inc

Zimmer Biomet Holdings Inc Reports Impressive 36.99% Surge in Profit Per Share, Alongside 4.928% Revenue Boost in Q2 2023 Earnings Season

Zimmer Biomet Holdings Inc, a prominent Medical Equipment & Supplies company, has experienced some significant developments in its stock performance in recent trading days. Over the course of the last five trading days, its stock saw a decline of -5.39%. However, despite this short-term setback, the year-to-date performance stands at a positive 3.92%. Currently, Zimmer Biomet Holdings Inc's stock is trading on the NYSE at a price 6.2% higher than its 52-week average.
Examining the financial results from the quarter ending on June 30, 2023, Zimmer Biomet Holdings Inc displayed impressive figures and growth in various areas. Notably, the company's earnings per share (EPS) significantly outpaced revenue growth, with a surge of 36.99% to reach $1.00 per share. Revenue also witnessed a solid advancement of 4.928% from the corresponding quarter a year before, increasing to $1.87 billion. In the prior quarter, the company achieved revenue of $1.83 billion and earned $1.11 per share.

Zimmer Biomet Holdings Inc

Strong Eps Underlines Double Digits revenue rise at in the first quarter of 2023

Zimmer Biomet Holdings Inc's latest financial report for the first quarter of 2023 showed improvements in its Return on Equity, with the ROE standing at 3.71% compared to the previous quarter's 1.92%. Despite this, the figure remains below the company's average return on equity of 4.57%. While nine other companies in the Biotechnology & Pharmaceuticals industry had a higher ROE, Zimmer Biomet's overall ranking for the metric improved in the first quarter, moving up to 529 from 2305 in the fourth quarter of 2022.
Investors will be pleased to note that Zimmer Biomet's earnings per share soared by an impressive 1485.71% to $1.11 in the first three months of 2023. Revenue also saw a significant increase, rising 10.089% to $1.83 billion, compared to the same period in the prior year. Net profits came in at $232.7 million, up from $14.4 million a year ago, reflecting a 1515.97% growth.






 

Zimmer Biomet Holdings Inc's Segments
 
 
• View Complete Report




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com